1 / 60

Communicable disease surveillance

Communicable disease surveillance. Robert Allard MDCM MSc FRCPC October 2004. Infectious disease surveillance designs. Traditional disease notification Outbreak investigation Cluster investigation Enhanced surveillance Sentinel surveillance Emerging infectious diseases

niel
Télécharger la présentation

Communicable disease surveillance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Communicable disease surveillance Robert Allard MDCM MSc FRCPC October 2004

  2. Infectious diseasesurveillance designs • Traditional disease notification • Outbreak investigation • Cluster investigation • Enhanced surveillance • Sentinel surveillance • Emerging infectious diseases • diagnosis-based surveillance • syndromic surveillance • Molecular biology and surveillance

  3. Definition “Surveillance, when applied to a disease, means • the continued watchfulness over the distribution and trends of incidence • through the systematic collection, consolidation and evaluation of morbidity and mortality reports and other relevant data. • Intrinsic in the concept is the regular dissemination of the basic data and interpretation to all who have contributed and to all others who need to know. • The concept, however, does not encompass direct responsibility for control activities.” A.D. Langmuir, 1963

  4. Ongoing Generates hypotheses Incomplete data on population Simpler analysis Rapid dissemination of results Results not necessarily generalizable Triggers intervention Time-limited Tests hypotheses Complete data on sample More complex analysis Slower dissemination of results Aims at generalizability Looser link to intervention COMMUNICABLE DISEASESURVEILLANCE or RESEARCH?

  5. Traditional disease notification • Legal framework • List of reportable (or notifiable) conditions • Verification and analysis • Investigation • Public health intervention • Dissemination of results • Evaluation and updating

  6. Legal framework • Required for • transmission of confidential information • investigation • intervention • Varies between jurisdictions • Québec specifics: • no more anonymously reportable conditions • HIV-AIDS is “provincially reportable” • duty to “signal” non-reportable conditions • distinction between “surveillance” and “vigie” • surveillance ethics committee

  7. DISEASE SELECTION CRITERIA • Incidence • Morbidity • Mortality / severity / lethality • Communicability / potential for outbreaks • Preventability • Changing pattern in previous 5 years • Socioeconomic burden • Public health response necessary • Public perception of risk • International and other sector consideration

  8. Rank (Priority for Canadian government, first 12 of 43) 1988 1998 1 Measles HIV 2 Tuberculosis AIDS 3 AIDS Laboratory confirmed influenza 4 Hepatitis B Tuberculosis 5 Pertussis Measles 6 Salmonellosis Rabies 7 Rubella Pertussis 8 H. influenzae Invasive meningococcal disease invasive disease 9 Diphtheria Hepatitis C 10 Chickenpox Botulism 11 Meningococcal Poliomyelitis infection 12 Gonococcal Creutzfeld-Jacob Disease infection

  9. VALIDITY OF REPORTS(False positives) • Surveillance definitions • May be different from clinical definitions • Laboratory confirmation • The problem of nearly eliminated diseases • Most positives are false positives • Poor clinical diagnostic accuracy • Importance of eliminating alternate Dx • Only confirmed cases enter statistics

  10. COMPLETENESS OF REPORTING(False negatives) • Varies by • Type of reporting (active, passive) • Source of reports • Disease • Need not be high, provided it is stable • More important if intervention is possible

  11. Stages in the reporting of shigellosis (CDC, ca. 1970)

  12. ROUTINE INVESTIGATIONOF REPORTED CASES • MD, patient and/or relative are interviewed • Not all cases can be investigated • Intervention possible • Transmissibility is high • Case is unusual • Outbreak is suspected

  13. ANALYSIS OF SURVEILLANCE DATA “Monitoring trends is the cornerstone objective of most surveillance systems.” Buehler, Modern Epidemiology (1998), p. 438

  14. Standard outputs • Periodic reports • Mail and internet • Monthly • Commented • Newsletter • Special alerts • fax and e-mail • Annual report

  15. MAIN MONTHLY SURVEILLANCEOUTPUT, MONTREAL

  16. Detail of preceding table:

  17. “Figure 1” analysis

  18. ANNUAL FORECASTS

  19. Importance of explainingthe main surveillance results Note explicative concernant les statistiques des maladies infectieuses à déclaration obligatoire (MADO) et autres maladies infectieuses sous surveillance Période 08 de l’année 2003 (semaines 29 à 32 13-07-2003 au 09-08-2003]) Shigellose L’excès significatif de cas de shigellose s’explique par une éclosion parmi le personnel d’un établissement de soins de Montréal. Quinze cas ont été identifiés, dont treize confirmés par culture (S. sonnei) et deux reliés épidémiologiquement à un cas confirmé. Les symptômes ont commencé entre le 14 et le 18 juillet. De plus, quelques cas ont été déclarés dans la communauté, dus au même agent, et apparemment reliés à un ou des restaurants. Les organismes impliqués dans l’enquête (DSP, CUVM, MAPAQ) ont exploré divers liens possibles entre tous ces cas. L’éclosion est maintenant considérée comme terminée et des aliments achetés à la cafétéria semblent être la source commune de l’infection pour les cas dans l’établissement. Remerciements à Mme Hélène Rodrigue pour l’information.

  20. Outbreak investigation • Time, place, personor • Who, what, where, when, why (how)? • How = by what mode of transmission? • Three basic modes: • Person-to-person • Common source • Vector-borne

  21. DESIGNS FOROUTBREAK INVESTIGATIONS • Descriptive • Common exposure • Suitable when exposure is very specific • Person to person contacts • Case-control • Controls are: • Other attendees at event who remained healthy • Population sample (often drawn by RDD) • Case-case • Controls are: • Cases of other reportable diseases • Cases of the same disease, causedby a different strain than caused the outbreak

  22. CLUSTERING:temporal and spatial Cluster: • “A geographically bounded group of occurrences • of sufficient size and concentration • to be unlikely to have occurred by chance.” (Knox, 1989)

  23. WHY THE INTERESTIN CLUSTERING? • Cases are effects. • If effects are clustered, their causes could also be. • Or they could be in fact the same cause. • A common cause may be easier to • identify (of all exposures, it is the one that cases share) • remove or control.

  24. TEMPORAL CLUSTERING • Based on time-series (of numbers of notified cases) • Time unit: • Week • Month (period) • Favourite statistical methods: • ARIMA or Box-Jenkins modelling • “Figure 1” method

  25. Box-Jenkins modelling:the time series and the forecasts

  26. SPATIAL CLUSTERING • Less useful for surveillance in urban compared to rural environments • Very many methods exist • Most require more or less unrealistic assumptions • Most promising: SaTScan (see satscan.org)

  27. Reported dead corvid sightings

  28. WNV-INFECTED CORVIDS (red)

  29. SMOOTHED MAPOF SAME INFECTED CORVIDS(Thanks to Christian Back)

  30. HUMAN WNV CASES(a few days later, Sept. 19, 2003)

  31. SaTScan v4.0.3 • _____________________________ • Program run on: Tue Sep 14 08:39:26 2004 • Purely Spatial analysis • scanning for clusters with • high rates using the Bernoulli model. • ________________________________________________________________ • SUMMARY OF DATA • Study period .........: 2004/1/4 - 2004/9/11 • Number of census areas: 12153 • Total population .....: 1996 • Total cases ..........: 68 • ________________________________________________________________ • MOST LIKELY CLUSTER • 1.Location IDs included.: 24490070, 24490072, 24490071, 24490075, • 24490125, 24490073, 24490074, 24490108, • 24490069, 24490078, 24490076 • Coordinates / radius..: (45.835072 N, 72.416458 W) / 3.35 km • Population............: 3 • Number of cases.......: 3 (0.10 expected) • Overall relative risk.: 29.353 • Log likelihood ratio..: 10.203094 • Monte Carlo rank......: 22/1000 • P-value...............: 0.022

  32. SECONDARY CLUSTERS • 2.Location IDs included.: 24650090, 24650089, 24650095, 24650092, • 24650091, 24650103, 24650087, 24650105, • 24650104, 24650094, 24650096 • Coordinates / radius..: (45.601601 N, 73.716415 W) / 0.75 km • Population............: 3 • Number of cases.......: 3 (0.10 expected) • Overall relative risk.: 29.353 • Log likelihood ratio..: 10.203094 • Monte Carlo rank......: 22/1000 • P-value...............: 0.022 • 3.Location IDs included.: 24570180, 24590138, 24570179, 24590137, • 24590133, 24590129, 24590131, 24570089, • 24590128, 24590132, 24590134, 24590130, • 24590139, 24590135, 24590119, 24590136, • 24590114, 24590115, 24590113 • Coordinates / radius..: (45.580250 N, 73.286354 W) / 3.73 km • Population............: 3 • Number of cases.......: 3 (0.10 expected) • Overall relative risk.: 29.353 • Log likelihood ratio..: 10.203094 • Monte Carlo rank......: 22/1000 • P-value...............: 0.022 • 4.Location IDs included.: 24700011, 24700010, 24700004, 24700003, • 24700009, 24700007, 24700002, 24700008, • 24700012, 24700058, 24700001, 24700006, • 24700005, 24700013, 24700060 • Coordinates / radius..: (45.294823 N, 73.843208 W) / 5.58 km • Population............: 5 • Number of cases.......: 3 (0.17 expected) • Overall relative risk.: 17.612 • Log likelihood ratio..: 6.904386 • Monte Carlo rank......: 263/1000 • P-value...............: 0.263

  33. Clusters, week 30, 2003 Cases

  34. Clusters, week 30, 2003 Controls

  35. GROWING IMPORTANCEOF ZOONOSES • vCJD, SARS, WNV, avian influenza, monkeypox, rabies etc. • Disease trends in other species have to be followed and related to trends in humans • Interdisciplinary collaboration essential • Worrisome development, but very stimulating work

  36. ENHANCED SURVEILLANCE • Priority problem identified • Concept is elastic: traditional surveillance plus any combination of • Extra resources allocated • Increased collaboration between government levels • Standardized data collection • Increased data quality control • Access to better laboratory tests • Increased analytic possibilities • Other surveillance methods • Greater potential to guide policy making?

  37. SENTINEL SURVEILLANCE • Does not seek completeness • Uses purposely selected sources of information • Prefers sources likely to observe earliest occurrence of phenomenon under surveillance • May be active or passive • Relies heavily on real-time communication • Positive findings often trigger other forms of surveillance

  38. CHOICE OF SENTINELS • Physicians • Pharmacies • Laboratories • Hospitals • Public health Units, etc. • Combination of sources (see http://www.cdc.gov/foodnet/surveys.htm)

  39. SUCCESS FACTORS (?) • Link to professional organizations • Keep it passive • Provide feedback and other benefits • Surveillance objectives must be • Relevant • Flexible • Suggested by participants

  40. IMPORTED FALCIPARUM MALARIA IN EUROPE • European Network on Surveillance of Imported Infectious Diseases • About 45 hospital departments of infectious diseases • 1659 patients seen in 1999-2000 • About 10% of all patients with malaria seen in Europe

  41. Results: • European travellers 48%Immigrants 52% • Country of infection: West Africa for 63% • Chemoprophylaxis had been taken by • 40% of travellers • 28% of immigrants • Lethality: 5 patients (all travellers) • Useful results, but is it surveillance? • Continuous collection, analysis, reporting? • No denominators or analysis of trends

  42. EMERGINGINFECTIOUS DISEASES • Strategic/political aspects of the concept • “Emerging infections are those diseases whose incidence has increased within the past two decades or … threatens to increase in the near future.” (NY ACAD SCI) • An emerging infection can be due to an agent • previously unknown • previously unknown in humans • previously unknown in a given area • previously non pathogenic or less pathogenic • previously non resistant to antibiotics • previously controlled by preventive measures

  43. 1973 Rotavirus 1977 Ebola virus 1977 Legionellosis 1981 HIV 1982 E.coli O157:H7 1982 Lyme disease 1983 H. pylori 1986 BSE, vCJD (prions) 1989 Hepatitis C 1992 Cholera O139 1995 HHV-8 1999 WNV 2001 Anthrax 2002 SARS CoV SOME EMERGING AGENTS

  44. FACTORS IN EMERGENCE • Microbial adaptation and change • Drug resistance • New virulence or toxin production • Environmental changes • Global warming • Deforestation • Societal events • Impoverishment • War • Immigration

  45. Human behaviour • Sexual, drug use • Travel • Use of child care facilities • Food production • Globalization • Health care • Widespread use of antibiotics (Clostridium difficile!) • Immunosuppressive drugs • Public health infrastructure • Curtailment of preventive programs

  46. EID: diagnosis-based surveillance • SARS: severe acute respiratory syndrome • Originated in SE Asia in November 2002 • Single agent suspected early (SARS CoV) • Importation to Toronto (“superspreader”) • Canada-wide alert in April 2003 • Canadian case definition based on WHO’s • This case definition was crucial to • Day-to-day surveillance and control activities • Description of outbreak

  47. Surveillance case definition: • Suspect Case: A person presenting with: • Fever (over 38 degrees Celsius) AND • Cough or breathing difficulty AND • One or more of the following exposures during the 10 days prior to the onset of symptoms: • Close contact with a person who is a suspect or probable case • Recent travel to an "Area with recent local transmission" of SARS outside of Canada • Recent travel or visit to an identified setting in Canada where exposure to SARS may have occurred (e.g., hospital [including any hospital with an occupied SARS unit], household, workplace, school, etc.). This includes inpatients, employees or visitors to an institution if the exposure setting is an institution.

  48. Probable Case: • A suspect case with radiographic evidence of infiltrates consistent with pneumoniaor respiratory distress syndrome (RDS) on chest x-ray (CXR). OR • A suspect case with autopsy findings consistent with the pathology of RDS without an identifiable cause. • Exclusion Criteria • A suspect or probable case should be excluded if an alternate diagnosis can fully explain their illness.

  49. SARS EPIDEMIC CURVE, CANADA, 2003

  50. EID: syndromic surveillance • Observes the occurrence not of diagnosed disease but of a pre-defined syndrome • Syndrome = “a pattern of symptoms indicative of some disease”, usually unidentified • The syndrome may be associated with one or more disease entities • A diagnosis is sought (for surveillance) only when a cluster of the syndrome is detected

More Related